Search Results - "Nielsen, P.B."

Maternal death due to extended spectrum β-lactamase-producing E. coli : A warning for the future? by Loughnan, B.A, Grover, M, Nielsen, P.B

“…Abstract We describe a maternal death due to necrotising fasciitis caused by an extended spectrum β-lactamase-producing Escherichia coli resistant to routinely…”
Get full text

The Elderly - Classified as Minimal Risk - Constitute the Main Reservoir for MRSA Endemic by Pirani, T, Nielsen, P.B, Malik, N

Get full text

Gene expression analysis of calcineurin isoforms in T-lymphocytes — a method applied on kidney-transplant recipients by Mortensen, D.M, Røge, R, Øzbay, A, Koefoed-Nielsen, P.B, Jørgensen, K.A

“…Abstract Background Tacrolimus exerts its immunosuppressive effect through inhibition of the intracellular enzyme calcineurin phosphatase (CaN). In this study,…”
Get full text

Revascularisation for Symptomatic Peripheral Artery Disease: External Applicability of the VOYAGER PAD Trial by Søgaard, M., Nielsen, P.B., Skjøth, F., Larsen, T.B., Eldrup, N.

Get full text

Risk of cerebrovascular events in intracerebral haemorrhage survivors with atrial fibrillation: the Danish Stroke Registry by Melgaard, L, Lip, G.Y.H, Larsen, T.B, Nielsen, P.B

“…Abstract Background In patients with atrial fibrillation (AF), who have suffered an intracerebral haemorrhage (ICH), the optimal stroke prevention strategy is…”
Get full text

PO-24: Incidence of venous thromboembolism following head and neck surgery stratified according to cancer: a Danish nation-wide cohort study by Albertsen, I.E., Lyhne, N.M., Larsen, T.B., Nielsen, P.B.

Get full text

Epidemiological Trends and Projections of Incidence, Prevalence, and Disease Related Mortality Associated With Peripheral Arterial Disease: Observations Using Nationwide Danish Data by Søgaard, M., Nielsen, P.B., Eldrup, N., Behrendt, C.-A., Nicolajsen, C.W., Lip, G.Y.H., Skjøth, F.

Get full text

Applicability of the VOYAGER trial criteria: a cohort study on patients in the nationwide Danish Vascular Registry by Soegaard, M, Nielsen, P.B, Skjoeth, F, Larsen, T.B, Eldrup, N

“…Abstract Introduction Peripheral artery disease (PAD) carries a high risk of debilitating stroke, myocardial infarction, and death. The VOYAGER PAD trial…”
Get full text

Risk of ischemic stroke and recurrent ICH in patients with atrial fibrillation presenting with incident ICH: an analysis from the Danish Stroke Registry by Nielsen, P.B, Soegaard, M, Skjoeth, F, Larsen, T.B, Lip, G.Y.H

“…Abstract Background Intracerebral haemorrhage (ICH) is a devastating vascular event, and secondary prevention is central to avoid cerebral complications. The…”
Get full text

Temporal Profile of Calcineurin Phosphatase Activity During Acute Allograft Rejection in the Heterotopic Rat Heart Transplantation Model by Karamperis, N, Koefoed-Nielsen, P.B, Marcussen, N, Østraat, Ø, Jørgensen, K.A

“…Abstract Background Regardless of the extensive worldwide use of calcineurin inhibitors, little is known about the behavior of calcineurin phosphatase (CaN)…”
Get full text

P368 Parents’ experiences when their child is diagnosed with cystic fibrosis in the newborn screening program by Nielsen, P.B., Jensen, C.S., Olesen, H.V.

Get full text

Temporal trends in medical cardioprotective treatment in patients with abdominal aortic aneurysms: A population-based national cohort study by Nicolajsen, C.W., Søgaard, M., Eldrup, N., Larsen, T.B., Goldhaber, S.Z., Nielsen, P.B.

Get full text

OC-08: The Khorana score and risk of venous thromboembolism in patients with cancer treated with immune checkpoint inhibitors by Overvad, T.F., Ording, A.G., Nielsen, P.B., Piazza, G., Noble, S., Larsen, T.B., Skjøth, F.

Get full text

Thromboembolic risk in non-anticoagulated atrial fibrillation patients with valvular heart disease and low CHA2DS2-VASc scores: are these patients truly low risk of stroke? by Melgaard, L, Overvad, T.F, Jensen, M, Lip, G.Y.H, Larsen, T.B, Nielsen, P.B

“…Abstract Background Patients with atrial fibrillation and valvular heart disease (VHD) beyond moderate-to-severe mitral stenosis and/or a mechanical prosthetic…”
Get full text

Thromboembolic events and major bleeding in frail patients with incident atrial fibrillation: a nationwide cohort study by Hojen, A.A, Soegaard, M, Nielsen, P.B, Skjoeth, F, Coleman, C.I, Lip, G.Y.H, Larsen, T.B

“…Abstract Background Growing evidence suggests that frail patients presenting with atrial fibrillation (AF) are less likely to receive adequate oral…”
Get full text

PO-100 Safety of direct oral anticoagulants and vitamin k antagonists in patients with atrial fibrillation and gastrointestinal or urological cancer by Ording, A.G., Søgaard, M., Skjøth, F., Grove, E.L., Larsen, T.B., Nielsen, P.B.

Get full text

P4567Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs) by Nielsen, P.B., Skjoeth, F., Larsen, T.B., Kjaeldgaard, J.N., Lip, G.Y.H.

Get full text

5768Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc by Nielsen, P.B., Skjoeth, F., Overvad, T.F., Larsen, T.B., Lip, G.Y.H.

Get full text

Risk of recurrence and bleeding with Rivaroxaban among patients with venous thromboembolism and active cancer by Søgaard, M., Nielsen, P.B., Skjøth, F., Kjældgaard, J.N., Larsen, T.B.

Get full text

Towards optimal use of antithrombotic therapy of people with cancer at the end of life: A research protocol for the development and implementation of the SERENITY shared decision support tool by Goedegebuur, J., Abbel, D., Accassat, S., Achterberg, W.P., Akbari, A., Arfuch, V.M., Baddeley, E., Bax, J.J., Becker, D., Bergmeijer, B., Bertoletti, L., Blom, J.W., Calvetti, A., Cannegieter, S.C., Castro, L., Chavannes, N.H., Coma-Auli, N., Couffignal, C., Edwards, A., Edwards, M., Enggaard, H., Font, C., Gava, A., Geersing, G.J., Geijteman, E.C.T., Greenley, S., Gregory, C., Gussekloo, J., Hoffmann, I., Højen, A.A., van den Hout, W.B., Huisman, M.V., Jacobsen, S., Jagosh, J., Johnson, M.J., Jørgensen, L., Juffermans, C.C.M., Kempers, E.K., Konstantinides, S., Kroder, A.F., Kruip, M.J.H.A., Lafaie, L., Langendoen, J.W., Larsen, T.B., Lifford, K., van der Linden, Y.M., Mahé, I., Maiorana, L., Maraveyas, A., Martens, E.S.L., Mayeur, D., van Mens, T.E., Mohr, K., Mooijaart, S.P., Murtagh, F.E.M., Nelson, A., Nielsen, P.B., Ording, A.G., Ørskov, M., Pearson, M., Poenou, G., Portielje, J.E.A., Raczkiewicz, D., Rasmussen, K., Trinks-Roerdink, E., Schippers, I., Seddon, K., Sexton, K., Sivell, S., Skjøth, F., Søgaard, M., Szmit, S., Trompet, S., Vassal, P., Visser, C., van Vliet, L.M., Wilson, E., Klok, F.A., Noble, S.I.R.

“…Even though antithrombotic therapy has probably little or even negative effects on the well-being of people with cancer during their last year of life,…”
Get full text